Barclays maintains Colgate-Palmolive at Equalweight, PT $84.00
A Barclays analyst maintained Colgate-Palmolive (NYSE: CL) at Equalweight and a price target of $84.00 from a prior price target of %currency%%price%. Prior to this rating,...
-
-
JPMorgan maintains Colgate-Palmolive at Overweight, PT $87.00
A JPMorgan analyst maintained Colgate-Palmolive (NYSE: CL) at Overweight and a price target of $87.00 from a prior price target of %currency%%price%. Prior to this rating,...
-
Morgan Stanley maintains Colgate-Palmolive at Overweight, PT $89.00
A Morgan Stanley analyst maintained Colgate-Palmolive (NYSE: CL) at Overweight and a price target of $89.00 from a prior price target of %currency%%price%. Prior to this rating,...
-
Colgate-Palmolive tops Q1 expectations despite cost pressures
Colgate-Palmolive (NYSE:CL) shares jumped more than 3% Friday on the back of its first quarter earnings and revenue beat. The consumer products company {{erl-7938||reported Q1 EPS of $0.73,...
-
Colgate-Palmolive earnings beat by $0.03, revenue topped estimates
Investing.com - Colgate-Palmolive (NYSE: CL) reported first quarter EPS of $0.73, $0.03 better than the analyst estimate of $0.70. Revenue for the quarter came in at $4.77B versus the...
-
Inflation reading, oil majors, Colgate reports: 3 things to watch
Investing.com -- Stocks were surging on Thursday because of strong earnings reports from a slew of companies, led by Meta Platforms Inc (NASDAQ:META). Tech stocks were leading the indexes...
-
Stifel maintains Colgate-Palmolive at Hold
A Stifel analyst maintained Colgate-Palmolive (NYSE: CL) at Hold and a price target of $83.00 from a prior price target of %currency%%price%. Prior to this rating, Colgate-Palmolive had 9...
-
JPMorgan maintains Colgate-Palmolive at Overweight
A JPMorgan analyst maintained Colgate-Palmolive (NYSE: CL) at Overweight and a price target of $85.00 from a prior price target of %currency%%price%. Prior to this rating,...
-
UBS maintains Colgate-Palmolive at Buy
An UBS analyst maintained Colgate-Palmolive (NYSE: CL) at Buy and a price target of $86.00 from a prior price target of %currency%%price%. Prior to this rating, Colgate-Palmolive had 11...
-
Colgate-Palmolive Raises Quarterly Dividend 2.1% to $0.48; 2.7% Yield
Colgate-Palmolive (CL) declared a quarterly dividend of $0.48 per share, or $1.92 annualized. This is a 2.1% increase from the prior dividend of $0.47.The dividend will be payable on May 15,...
-
Colgate-Palmolive shares gain as Morgan Stanley says the recent pullback offers a good entry point
By Sam Boughedda Morgan Stanley analysts upgraded Colgate-Palmolive (NYSE:CL) to Overweight from Equal-Weight with a price target of $82 per share on Monday. The analysts also labeled the...
-
Colgate-Palmolive tops Q4 consensus expectations
By Sam Boughedda Colgate-Palmolive (NYSE:CL) shares fell before the open Friday in reaction to its latest earnings report in which the company topped earnings and revenue consensus...
-
Colgate-Palmolive Tops Q4 EPS by 1c, Beats on Revenue
Colgate-Palmolive (CL) reported Q4 EPS of $0.77, $0.01 better than the analyst estimate of $0.76. Revenue for the quarter came in at $4.63 billion versus the consensus estimate of $4.57...
-
Colgate-Palmolive earnings beat by $0.01, revenue topped estimates
Investing.com - Colgate-Palmolive (NYSE: CL) reported fourth quarter EPS of $0.77, $0.01 better than the analyst estimate of $0.76. Revenue for the quarter came in at $4.63B versus the...
-
Daniel Loeb: 'We have already seen the revenge of the value nerds...more to come'
By Daniel Shvartsman Investing.com -- Famed investor Daniel Loeb, Chief Investment Officer and CEO at Third Point LLC, called for more of the same in 2023 after a 2022 that saw a sea change...
-
Blue chip FMCG stock to BUY for an upside of 18%; Are you holding it?
Prabha Narasimhan, former senior executive director at HUL took over as Colgate-Palmolive’s early September this year. She disclosed her plans for the growth of the FMCG giant in the...
-
Colgate-Palmolive Reports In-Line Q3 EPS; Raises FY Organic Sales Guidance
Colgate-Palmolive (CL) reported Q3 EPS of $0.74, in-line with the analyst estimate of $0.74. Revenue for the quarter came in at $4.46 billion versus the consensus estimate of $4.48...
-
Colgate-Palmolive earnings inline, Revenue misses in Q3
Investing.com - Colgate-Palmolive (NYSE:CL) reported on Friday third quarter {{erl-7938||earnings that matched analysts' forecasts and revenue that fell short of...
-
Colgate-Palmolive India earnings beat, Revenue misses in Q2
Investing.com - Colgate-Palmolive (NYSE:CL) India reported on Thursday second quarter {{erl-18076||earnings that beat analysts' forecasts and revenue that fell short of...
-
3 Rumors Buzzing Around Wall Street Today
By Investing.com Staff Stocks continued their positive run today as earnings continued to trickle in better than expected. Today, Goldman Sachs (NYSE:GS), Johnson & Johnson, and...
-
Third Point Builds a Position in Colgate-Palmolive According to CNBC's David Faber
By Sam Boughedda Hedge fund manager Dan Loeb, the founder and chief executive of Third Point, has accumulated a stake in Colgate-Palmolive (NYSE:CL), CNBC's David Faber revealed on...
-
IIM-L scores 100% placement
Lucknow, Oct 10 (IANS) The Indian Institute of Management, Lucknow (IIM-L) has scored 100 per cent placement in its summer placement drive. The drive -- held for the 38th batch of Post...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
